List of Tables
Table 1. Global Injectable Ketamine Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global Injectable Ketamine Market Value by Application (US$ Million), 2025 vs 2032
Table 3. Global Injectable Ketamine Market Competitive Situation by Manufacturers in 2025
Table 4. Global Injectable Ketamine Sales (kg) of Key Manufacturers (2021–2026)
Table 5. Global Injectable Ketamine Sales Market Share by Manufacturers (2021–2026)
Table 6. Global Injectable Ketamine Revenue (US$ Million) by Manufacturers (2021–2026)
Table 7. Global Injectable Ketamine Revenue Share by Manufacturers (2021–2026)
Table 8. Global Market Injectable Ketamine Average Price (US$/kg) of Key Manufacturers (2021–2026)
Table 9. Global Key Players of Injectable Ketamine, Industry Ranking, 2023 vs 2024 vs 2025
Table 10. Global Key Manufacturers of Injectable Ketamine, Manufacturing Sites and Headquarters
Table 11. Global Key Manufacturers of Injectable Ketamine, Product Types and Applications
Table 12. Global Key Manufacturers of Injectable Ketamine, Date of Entry into the Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Injectable Ketamine Companies by Tier (Tier 1, Tier 2, Tier 3), based on Injectable Ketamine Revenue, 2025
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Injectable Ketamine Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 17. Global Injectable Ketamine Sales by Region (kg), 2021–2026
Table 18. Global Injectable Ketamine Sales Market Share by Region (2021–2026)
Table 19. Global Injectable Ketamine Sales by Region (kg), 2027–2032
Table 20. Global Injectable Ketamine Sales Market Share by Region (2027–2032)
Table 21. Global Injectable Ketamine Revenue by Region (US$ Million), 2021–2026
Table 22. Global Injectable Ketamine Revenue Market Share by Region (2021–2026)
Table 23. Global Injectable Ketamine Revenue by Region (US$ Million), 2027–2032
Table 24. Global Injectable Ketamine Revenue Market Share by Region (2027–2032)
Table 25. North America Injectable Ketamine Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 26. North America Injectable Ketamine Sales by Country (kg), 2021–2026
Table 27. North America Injectable Ketamine Sales by Country (kg), 2027–2032
Table 28. North America Injectable Ketamine Revenue by Country (US$ Million), 2021–2026
Table 29. North America Injectable Ketamine Revenue by Country (US$ Million), 2027–2032
Table 30. Europe Injectable Ketamine Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 31. Europe Injectable Ketamine Sales by Country (kg), 2021–2026
Table 32. Europe Injectable Ketamine Sales by Country (kg), 2027–2032
Table 33. Europe Injectable Ketamine Revenue by Country (US$ Million), 2021–2026
Table 34. Europe Injectable Ketamine Revenue by Country (US$ Million), 2027–2032
Table 35. Asia Pacific Injectable Ketamine Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 36. Asia Pacific Injectable Ketamine Sales by Region (kg), 2021–2026
Table 37. Asia Pacific Injectable Ketamine Sales by Region (kg), 2027–2032
Table 38. Asia Pacific Injectable Ketamine Revenue by Region (US$ Million), 2021–2026
Table 39. Asia Pacific Injectable Ketamine Revenue by Region (US$ Million), 2027–2032
Table 40. Latin America Injectable Ketamine Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 41. Latin America Injectable Ketamine Sales by Country (kg), 2021–2026
Table 42. Latin America Injectable Ketamine Sales by Country (kg), 2027–2032
Table 43. Latin America Injectable Ketamine Revenue by Country (US$ Million), 2021–2026
Table 44. Latin America Injectable Ketamine Revenue by Country (US$ Million), 2027–2032
Table 45. Middle East and Africa Injectable Ketamine Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 46. Middle East and Africa Injectable Ketamine Sales by Country (kg), 2021–2026
Table 47. Middle East and Africa Injectable Ketamine Sales by Country (kg), 2027–2032
Table 48. Middle East and Africa Injectable Ketamine Revenue by Country (US$ Million), 2021–2026
Table 49. Middle East and Africa Injectable Ketamine Revenue by Country (US$ Million), 2027–2032
Table 50. Global Injectable Ketamine Sales (kg) by Type (2021–2026)
Table 51. Global Injectable Ketamine Sales (kg) by Type (2027–2032)
Table 52. Global Injectable Ketamine Sales Market Share by Type (2021–2026)
Table 53. Global Injectable Ketamine Sales Market Share by Type (2027–2032)
Table 54. Global Injectable Ketamine Revenue (US$ Million) by Type (2021–2026)
Table 55. Global Injectable Ketamine Revenue (US$ Million) by Type (2027–2032)
Table 56. Global Injectable Ketamine Revenue Market Share by Type (2021–2026)
Table 57. Global Injectable Ketamine Revenue Market Share by Type (2027–2032)
Table 58. Global Injectable Ketamine Price (US$/kg) by Type (2021–2026)
Table 59. Global Injectable Ketamine Price (US$/kg) by Type (2027–2032)
Table 60. Global Injectable Ketamine Sales (kg) by Application (2021–2026)
Table 61. Global Injectable Ketamine Sales (kg) by Application (2027–2032)
Table 62. Global Injectable Ketamine Sales Market Share by Application (2021–2026)
Table 63. Global Injectable Ketamine Sales Market Share by Application (2027–2032)
Table 64. Global Injectable Ketamine Revenue (US$ Million) by Application (2021–2026)
Table 65. Global Injectable Ketamine Revenue (US$ Million) by Application (2027–2032)
Table 66. Global Injectable Ketamine Revenue Market Share by Application (2021–2026)
Table 67. Global Injectable Ketamine Revenue Market Share by Application (2027–2032)
Table 68. Global Injectable Ketamine Price (US$/kg) by Application (2021–2026)
Table 69. Global Injectable Ketamine Price (US$/kg) by Application (2027–2032)
Table 70. Greenco Biologicals Company Information
Table 71. Greenco Biologicals Description and Business Overview
Table 72. Greenco Biologicals Injectable Ketamine Sales (kg), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)
Table 73. Greenco Biologicals Injectable Ketamine Product
Table 74. Greenco Biologicals Recent Developments/Updates
Table 75. Pfizer Company Information
Table 76. Pfizer Description and Business Overview
Table 77. Pfizer Injectable Ketamine Sales (kg), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)
Table 78. Pfizer Injectable Ketamine Product
Table 79. Pfizer Recent Developments/Updates
Table 80. BNM Organics Company Information
Table 81. BNM Organics Description and Business Overview
Table 82. BNM Organics Injectable Ketamine Sales (kg), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)
Table 83. BNM Organics Injectable Ketamine Product
Table 84. BNM Organics Recent Developments/Updates
Table 85. Seqens Company Information
Table 86. Seqens Description and Business Overview
Table 87. Seqens Injectable Ketamine Sales (kg), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)
Table 88. Seqens Injectable Ketamine Product
Table 89. Seqens Recent Developments/Updates
Table 90. Troikaa Parenterals Company Information
Table 91. Troikaa Parenterals Description and Business Overview
Table 92. Troikaa Parenterals Injectable Ketamine Sales (kg), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)
Table 93. Troikaa Parenterals Injectable Ketamine Product
Table 94. Troikaa Parenterals Recent Developments/Updates
Table 95. Neon Laboratories Company Information
Table 96. Neon Laboratories Description and Business Overview
Table 97. Neon Laboratories Injectable Ketamine Sales (kg), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)
Table 98. Neon Laboratories Injectable Ketamine Product
Table 99. Neon Laboratories Recent Developments/Updates
Table 100. Samarth Pharma Company Information
Table 101. Samarth Pharma Description and Business Overview
Table 102. Samarth Pharma Injectable Ketamine Sales (kg), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)
Table 103. Samarth Pharma Injectable Ketamine Product
Table 104. Samarth Pharma Recent Developments/Updates
Table 105. Sun Pharmaceuticals Company Information
Table 106. Sun Pharmaceuticals Description and Business Overview
Table 107. Sun Pharmaceuticals Injectable Ketamine Sales (kg), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)
Table 108. Sun Pharmaceuticals Injectable Ketamine Product
Table 109. Sun Pharmaceuticals Recent Developments/Updates
Table 110. Supriya Lifesciences Company Information
Table 111. Supriya Lifesciences Description and Business Overview
Table 112. Supriya Lifesciences Injectable Ketamine Sales (kg), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)
Table 113. Supriya Lifesciences Injectable Ketamine Product
Table 114. Supriya Lifesciences Recent Developments/Updates
Table 115. Taj Pharmaceuticals Company Information
Table 116. Taj Pharmaceuticals Description and Business Overview
Table 117. Taj Pharmaceuticals Injectable Ketamine Sales (kg), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)
Table 118. Taj Pharmaceuticals Injectable Ketamine Product
Table 119. Taj Pharmaceuticals Recent Developments/Updates
Table 120. Hengrui Company Information
Table 121. Hengrui Description and Business Overview
Table 122. Hengrui Injectable Ketamine Sales (kg), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)
Table 123. Hengrui Injectable Ketamine Product
Table 124. Hengrui Recent Developments/Updates
Table 125. Anhui Wanhe Pharmaceutical Company Information
Table 126. Anhui Wanhe Pharmaceutical Description and Business Overview
Table 127. Anhui Wanhe Pharmaceutical Injectable Ketamine Sales (kg), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)
Table 128. Anhui Wanhe Pharmaceutical Injectable Ketamine Product
Table 129. Anhui Wanhe Pharmaceutical Recent Developments/Updates
Table 130. Ketalar Company Information
Table 131. Ketalar Description and Business Overview
Table 132. Ketalar Injectable Ketamine Sales (kg), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)
Table 133. Ketalar Injectable Ketamine Product
Table 134. Ketalar Recent Developments/Updates
Table 135. Hameln Pharma ltd Company Information
Table 136. Hameln Pharma ltd Description and Business Overview
Table 137. Hameln Pharma ltd Injectable Ketamine Sales (kg), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)
Table 138. Hameln Pharma ltd Injectable Ketamine Product
Table 139. Hameln Pharma ltd Recent Developments/Updates
Table 140. Key Raw Materials Lists
Table 141. Raw Materials Key Suppliers Lists
Table 142. Injectable Ketamine Distributors List
Table 143. Injectable Ketamine Customers List
Table 144. Injectable Ketamine Market Trends
Table 145. Injectable Ketamine Market Drivers
Table 146. Injectable Ketamine Market Challenges
Table 147. Injectable Ketamine Market Restraints
Table 148. Research Programs/Design for This Report
Table 149. Key Data Information from Secondary Sources
Table 150. Key Data Information from Primary Sources
Table 151. Authors List of This Report
List of Figures
Figure 1. Product Picture of Injectable Ketamine
Figure 2. Global Injectable Ketamine Market Value by Type (US$ Million), 2021–2032
Figure 3. Global Injectable Ketamine Market Share by Type: 2025 & 2032
Figure 4. Low-Dose Ketamine Product Picture
Figure 5. Standard Ketamine Product Picture
Figure 6. High-Dose Ketamine Product Picture
Figure 7. Global Injectable Ketamine Market Value by Application (US$ Million), 2021–2032
Figure 8. Global Injectable Ketamine Market Share by Application: 2025 & 2032
Figure 9. Anesthetic Use
Figure 10. Pain Management
Figure 11. Mental Health Treatment
Figure 12. Global Injectable Ketamine Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 13. Global Injectable Ketamine Market Size (US$ Million), 2021–2032
Figure 14. Global Injectable Ketamine Sales (kg), 2021–2032
Figure 15. Global Injectable Ketamine Average Price (US$/kg), 2021–2032
Figure 16. Injectable Ketamine Report Years Considered
Figure 17. Injectable Ketamine Sales Share by Manufacturers in 2025
Figure 18. Global Injectable Ketamine Revenue Share by Manufacturers in 2025
Figure 19. Top 5 and Top 10 Global Injectable Ketamine Players: Market Share by Revenue in Injectable Ketamine in 2025
Figure 20. Injectable Ketamine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 21. Global Injectable Ketamine Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 22. North America Injectable Ketamine Sales Market Share by Country (2021–2032)
Figure 23. North America Injectable Ketamine Revenue Market Share by Country (2021–2032)
Figure 24. United States Injectable Ketamine Revenue Growth Rate (US$ Million), 2021–2032
Figure 25. Canada Injectable Ketamine Revenue Growth Rate (US$ Million), 2021–2032
Figure 26. Europe Injectable Ketamine Sales Market Share by Country (2021–2032)
Figure 27. Europe Injectable Ketamine Revenue Market Share by Country (2021–2032)
Figure 28. Germany Injectable Ketamine Revenue Growth Rate (US$ Million), 2021–2032
Figure 29. France Injectable Ketamine Revenue Growth Rate (US$ Million), 2021–2032
Figure 30. U.K. Injectable Ketamine Revenue Growth Rate (US$ Million), 2021–2032
Figure 31. Italy Injectable Ketamine Revenue Growth Rate (US$ Million), 2021–2032
Figure 32. Russia Injectable Ketamine Revenue Growth Rate (US$ Million), 2021–2032
Figure 33. Asia Pacific Injectable Ketamine Sales Market Share by Region (2021–2032)
Figure 34. Asia Pacific Injectable Ketamine Revenue Market Share by Region (2021–2032)
Figure 35. China Injectable Ketamine Revenue Growth Rate (US$ Million), 2021–2032
Figure 36. Japan Injectable Ketamine Revenue Growth Rate (US$ Million), 2021–2032
Figure 37. South Korea Injectable Ketamine Revenue Growth Rate (US$ Million), 2021–2032
Figure 38. India Injectable Ketamine Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. Australia Injectable Ketamine Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. China Taiwan Injectable Ketamine Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. Southeast Asia Injectable Ketamine Revenue Growth Rate (US$ Million), 2021–2032
Figure 42. Latin America Injectable Ketamine Sales Market Share by Country (2021–2032)
Figure 43. Latin America Injectable Ketamine Revenue Market Share by Country (2021–2032)
Figure 44. Mexico Injectable Ketamine Revenue Growth Rate (US$ Million), 2021–2032
Figure 45. Brazil Injectable Ketamine Revenue Growth Rate (US$ Million), 2021–2032
Figure 46. Argentina Injectable Ketamine Revenue Growth Rate (US$ Million), 2021–2032
Figure 47. Colombia Injectable Ketamine Revenue Growth Rate (US$ Million), 2021–2032
Figure 48. Middle East and Africa Injectable Ketamine Sales Market Share by Country (2021–2032)
Figure 49. Middle East and Africa Injectable Ketamine Revenue Market Share by Country (2021–2032)
Figure 50. Turkey Injectable Ketamine Revenue Growth Rate (US$ Million), 2021–2032
Figure 51. Saudi Arabia Injectable Ketamine Revenue Growth Rate (US$ Million), 2021–2032
Figure 52. UAE Injectable Ketamine Revenue Growth Rate (US$ Million), 2021–2032
Figure 53. Global Sales Market Share of Injectable Ketamine by Type (2021–2032)
Figure 54. Global Revenue Market Share of Injectable Ketamine by Type (2021–2032)
Figure 55. Global Injectable Ketamine Price (US$/kg) by Type (2021–2032)
Figure 56. Global Sales Market Share of Injectable Ketamine by Application (2021–2032)
Figure 57. Global Revenue Market Share of Injectable Ketamine by Application (2021–2032)
Figure 58. Global Injectable Ketamine Price (US$/kg) by Application (2021–2032)
Figure 59. Injectable Ketamine Value Chain
Figure 60. Channels of Distribution (Direct Vs Distribution)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
